
Pregnancy Test Kits Market Report 2026
Global Outlook – By Type (Blood Test For Human Chorionic Gonadotropin (HCG), Urine Test For Human Chorionic Gonadotropin (HCG)), By Distribution Channel (Retail, Online), By Application (Hospitals, Clinics, Households, Pharmacies), By End-Users (Professionals, Home-Based) - Market Size, Trends, And Global Forecast 2026-2035
Pregnancy Test Kits Market Overview
• Pregnancy Test Kits market size has reached to $1.87 billion in 2025 • Expected to grow to $2.6 billion in 2030 at a compound annual growth rate (CAGR) of 7% • Growth Driver: Rising Telehealth Adoption Driving Demand For The Market Due To Cost-Efficient Remote Healthcare And At-Home Diagnostic Convenience • Market Trend: Innovations In Non-Invasive Pregnancy Testing For Enhanced Convenience And Accuracy • North America was the largest region in 2025 and Asia Pacific is the fastest growing region.What Is Covered Under Pregnancy Test Kits Market?
Pregnancy test kits are convenient, over-the-counter tools designed to detect the hormone human chorionic gonadotropin (hCG) in a woman’s urine, a key indicator of early pregnancy. These kits are user-friendly, allowing women to test in the privacy of their homes with simple instructions. The main types of pregnancy test kits are blood tests for human chorionic gonadotropin (HCG) and urine tests for human chorionic gonadotropin (HCG). Blood tests for human chorionic gonadotropin (hCG) are laboratory tests that measure the level of the hCG hormone in the bloodstream. hCG is produced primarily by the placenta shortly after a fertilized egg implants in the uterus, making it a key marker for detecting and monitoring pregnancy. These kits are distributed through various channels, including retail and online, and find applications in hospitals, clinics, households, and pharmacies, and serve end-users such as professionals and home-based users.
What Is The Pregnancy Test Kits Market Size and Share 2026?
The pregnancy test kits market size has grown strongly in recent years. It will grow from $1.87 billion in 2025 to $1.98 billion in 2026 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to increased awareness of reproductive health, widespread availability of OTC diagnostic products, expansion of retail pharmacy networks, rising use of home-based testing, improvements in hcg detection sensitivity.What Is The Pregnancy Test Kits Market Growth Forecast?
The pregnancy test kits market size is expected to see strong growth in the next few years. It will grow to $2.6 billion in 2030 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to increasing demand for connected health diagnostics, rising focus on women’s health technologies, expansion of telehealth-supported testing, growing adoption of digital readout tests, increasing emphasis on sustainability in diagnostic products. Major trends in the forecast period include increasing adoption of digital pregnancy test kits, rising demand for early and accurate detection, growing preference for at-home diagnostic solutions, expansion of online distribution channels, enhanced focus on user-friendly test design.Global Pregnancy Test Kits Market Segmentation
1) By Type: Blood Test For Human Chorionic Gonadotropin (HCG), Urine Test For Human Chorionic Gonadotropin (HCG) 2) By Distribution Channel: Retail, Online 3) By Application: Hospitals, Clinics, Households, Pharmacies 4) By End-Users: Professionals, Home-Based Subsegments: 1) By Blood Test For Human Chorionic Gonadotropin (HCG): Qualitative Blood Test, Quantitative Blood Test 2) By Urine Test For Human Chorionic Gonadotropin (HCG): Midstream Tests, Cassette Tests, Digital TestsWhat Are The Drivers Of The Pregnancy Test Kits Market?
The growth in telehealth adoption is expected to propel the growth of the pregnancy test kits market going forward. Telehealth adoption refers to the increasing use of digital communication technologies to deliver healthcare services remotely by providers and patients. Telehealth adoption is increasing due to cost efficiency, as virtual consultations lower healthcare delivery costs by reducing hospital visits, infrastructure burden, and associated patient expenses. Pregnancy test kits support telehealth adoption by enabling early at-home pregnancy detection, allowing users to quickly share results with healthcare providers through teleconsultations and receive timely guidance, follow-up care, or prescriptions without an in-person visit. For instance, in September 2024, according to the Australian Bureau of Statistics (ABS), the national statistical agency of Australia, in 2023–24, 83.5% of males reported using telehealth services, an increase from 78.6% in 2022–23. Therefore, the growth in telehealth adoption is driving the growth of the pregnancy test kits industry. The expanding infertility rates are expected to propel the growth of the pregnancy test kits market going forward. Infertility rates refer to the percentage of couples or individuals of reproductive age who are unable to conceive after 12 months of regular, unprotected intercourse. Increasing infertility rates are partly driven by lifestyle factors such as poor diet, obesity, smoking, and stress, which disrupt hormonal balance and impair reproductive health. Pregnancy test kits help address infertility by enabling early detection of conception or identifying difficulties in conceiving, allowing couples and doctors to seek timely fertility evaluation and treatment. For instance, in April 2023, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, approximately 17.5% of the adult population, or about 1 in 6 people globally, face infertility, highlighting the pressing need to improve access to affordable, high-quality fertility care for those affected. Therefore, the expanding infertility rates are driving the growth of the pregnancy test kits industry.Key Players In The Global Pregnancy Test Kits Market
Major companies operating in the pregnancy test kits market are Johnson & Johnson, Procter & Gamble Co, Abbott Laboratories, Church & Dwight Co Inc, Alere Inc, Piramal Enterprises Ltd, Quidel Corporation, Mankind Pharma, Cardinal Health Inc, EKF Diagnostics Holdings PLC, Sugentech Inc, Egens Group, INTEC Group, Medsource Ozone Biomedicals, SPD Swiss Precision Diagnostics, Geratherm Medical AG, Princeton BioMeditech Corporation, Cupid Limited, Easy Healthcare Corporation, Axis Medicare Ltd, AccuQuik Test Kits, Sara Health Care Pvt Ltd, Hicks Thermometers India Limited, Fairhaven Health LLCGlobal Pregnancy Test Kits Market Trends and Insights
Major companies operating in the pregnancy test kits market are focusing on developing innovative solutions such as saliva-based pregnancy tests to enhance user convenience, enable non-invasive testing, and improve early detection accuracy. A saliva-based pregnancy test refers to a diagnostic kit that detects pregnancy by analyzing a woman’s saliva for the presence of human chorionic gonadotropin (hCG), the hormone produced during early pregnancy, offering a non-invasive and convenient alternative to traditional urine-based tests. For instance, in June 2023, Salignostics Ltd., an Israel-based biotech company, launched a Salistick to provide a convenient, non-invasive saliva-based pregnancy testing solution. It detects the β-hCG hormone with over 96% accuracy as early as one day after a missed period. Its key advantages include no urine collection, enabling hygienic, private testing anywhere without bathroom access, and using a simple foam stick for results in 5-15 minutes. Benefits encompass enhanced user comfort, partner-sharing convenience, and reliable performance matching traditional tests while serving global at-home diagnostics.What Are Latest Mergers And Acquisitions In The Pregnancy Test Kits Market?
In February 2023, Vistagen Therapeutics Inc., a US-based clinical-stage biopharmaceutical company, acquired Pherin Pharmaceuticals Inc. for an undisclosed amount. This acquisition enables Vistagen to develop and commercialize innovative treatments for individuals with depression and anxiety disorders. This deal is expected to significantly improve each drug candidate's potential future commercial profile. Pherin Pharmaceuticals Inc. is a US-based pharmaceutical company specializing in drug development for panic disorders.Regional Outlook
North America was the largest region in the pregnancy test kits market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Pregnancy Test Kits Market?
The pregnancy test kits market consists of sales of laboratory-based pregnancy test kits, home-use pregnancy test kits, clinical pregnancy detection kits and over-the-counter pregnancy test kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Pregnancy Test Kits Market Report 2026?
The pregnancy test kits market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pregnancy test kits industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Pregnancy Test Kits Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $1.98 billion |
| Revenue Forecast In 2035 | $2.6 billion |
| Growth Rate | CAGR of 5.9% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Type, Distribution Channel, Application, End-Users |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Johnson & Johnson, Procter & Gamble Co, Abbott Laboratories, Church & Dwight Co Inc, Alere Inc, Piramal Enterprises Ltd, Quidel Corporation, Mankind Pharma, Cardinal Health Inc, EKF Diagnostics Holdings PLC, Sugentech Inc, Egens Group, INTEC Group, Medsource Ozone Biomedicals, SPD Swiss Precision Diagnostics, Geratherm Medical AG, Princeton BioMeditech Corporation, Cupid Limited, Easy Healthcare Corporation, Axis Medicare Ltd, AccuQuik Test Kits, Sara Health Care Pvt Ltd, Hicks Thermometers India Limited, Fairhaven Health LLC |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
